{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:58:56Z","timestamp":1792706336320,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.diabres.2024.111961","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T16:25:47Z","timestamp":1734452747000},"page":"111961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Temporal incremental healthcare costs associated with complications in Hong Kong Chinese patients with type 2 diabetes: A prospective study in Joint Asia diabetes evaluation (JADE) Register (2007\u20132019)"],"prefix":"10.1016","volume":"219","author":[{"given":"Juliana N.M.","family":"Lui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.H.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby Q.Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Ling","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Chun-KwunO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly T.C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.W.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice P.S.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea O.Y.","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Y.K.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana C.N.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2024.111961_b0005","doi-asserted-by":"crossref","unstructured":"Liu J, Liu M, Chai Z, Li C, Wang Y, Shen M, Zhuang G, Zhang L. Projected rapid growth in diabetes disease burden and economic burden in China: a spatio-temporal study from 2020 to 2030. The Lancet Regional Health \u2013 Western Pacific. 2023;33.","DOI":"10.1016\/j.lanwpc.2023.100700"},{"key":"10.1016\/j.diabres.2024.111961_b0010","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: International Diabetes Federation; 2021."},{"issue":"1","key":"10.1016\/j.diabres.2024.111961_b0015","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1186\/s12913-020-05897-w","article-title":"Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies","volume":"20","author":"Stegbauer","year":"2020","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"10.1016\/j.diabres.2024.111961_b0020","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40273-015-0268-9","article-title":"The economic costs of type 2 diabetes: a global systematic review","volume":"33","author":"Seuring","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.diabres.2024.111961_b0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/nyas.12098","article-title":"Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States","volume":"1281","author":"Ma","year":"2013","journal-title":"Ann N Y Acad Sci"},{"issue":"20","key":"10.1016\/j.diabres.2024.111961_b0030","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1001\/jama.2009.726","article-title":"Diabetes in Asia: epidemiology, risk factors, and pathophysiology","volume":"301","author":"Chan","year":"2009","journal-title":"J Am Med Assoc"},{"issue":"19","key":"10.1016\/j.diabres.2024.111961_b0035","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030766","article-title":"Impact of new cardiovascular events on quality of life and hospital costs in people with cardiovascular disease in the United Kingdom and United States","volume":"12","author":"Lui","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.diabres.2024.111961_b0040","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/14737167.2019.1661777","article-title":"Epidemiological characteristics, medical costs and healthcare resource utilization of diabetes-related complications among Chinese patients with type 2 diabetes mellitus","volume":"20","author":"Duan","year":"2020","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"6","key":"10.1016\/j.diabres.2024.111961_b0045","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/dom.13253","article-title":"Direct medical costs of diabetes mellitus in the year of mortality and year preceding the year of mortality","volume":"20","author":"Wong","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"10.1016\/j.diabres.2024.111961_b0050","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/dme.13416","article-title":"Annual direct medical costs associated with diabetes-related complications in the event year and in subsequent years in Hong Kong","volume":"34","author":"Jiao","year":"2017","journal-title":"Diabet Med"},{"issue":"31","key":"10.1016\/j.diabres.2024.111961_b0055","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011602","article-title":"Healthcare costs and utilization of diabetes-related complications in Taiwan: a claims database analysis","volume":"97","author":"Cheng","year":"2018","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.diabres.2024.111961_b0060","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1111\/dom.14796","article-title":"Hospital costs associated with adverse events in people with diabetes in the UK","volume":"24","author":"Keng","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"10.1016\/j.diabres.2024.111961_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107735","article-title":"Estimating costs of diabetes complications in people <65 years in the U.S. using panel data","volume":"34","author":"Yang","year":"2020","journal-title":"J Diabetes Complications"},{"issue":"5","key":"10.1016\/j.diabres.2024.111961_b0070","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc17-1763","article-title":"Health care costs associated with incident complications in patients with type 2 diabetes in Germany","volume":"41","author":"K\u00e4hm","year":"2018","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.diabres.2024.111961_b0075","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.diabres.2024.111961_b0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2024.111961_b0085","article-title":"Comorbidity measures for use with administrative data","volume":"8\u201327","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"4","key":"10.1016\/j.diabres.2024.111961_b0090","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/dme.12647","article-title":"The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84)","volume":"32","author":"Alva","year":"2015","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.diabres.2024.111961_b0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00019053-200927010-00008","article-title":"Estimating the cost of diabetes mellitus-related events from inpatient admissions in Sweden using administrative hospitalization data","volume":"27","author":"Gerdtham","year":"2009","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.diabres.2024.111961_b0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s12913-022-07895-6","article-title":"Hospital treatment costs associated with incident complications in patients with type 2 diabetes\u2014real-world study based on electronic patient information systems","volume":"22","author":"Sund","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"10.1016\/j.diabres.2024.111961_b0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1524-4733.2007.00228.x","article-title":"Estimating the cost of complications of diabetes in Australia using administrative health-care data","volume":"11","author":"Clarke","year":"2008","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.diabres.2024.111961_b0110","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/jdi.13308","article-title":"Healthcare utilization and direct medical cost in the years during and after cancer diagnosis in patients with type 2 diabetes mellitus","volume":"11","author":"Wu","year":"2020","journal-title":"J Diabetes Investig"},{"issue":"2","key":"10.1016\/j.diabres.2024.111961_b0115","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14970","article-title":"Incremental healthcare costs attributable to type 2 diabetes in Hong Kong: a population-based cost of illness study","volume":"40","author":"Quan","year":"2023","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.diabres.2024.111961_b0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3111\/13696998.2014.882843","article-title":"Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012)","volume":"17","author":"Ward","year":"2014","journal-title":"J Med Econ"},{"issue":"6","key":"10.1016\/j.diabres.2024.111961_b0125","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40258-023-00830-8","article-title":"Evaluating the short-term costs and benefits of a nationwide diabetes prevention programme in England: retrospective observational study","volume":"21","author":"McManus","year":"2023","journal-title":"Appl Health Econ Health Policy"},{"issue":"1","key":"10.1016\/j.diabres.2024.111961_b0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12933-023-01772-0","article-title":"Risks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based cohort study in Hong Kong","volume":"22","author":"Lui","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"10.1016\/j.diabres.2024.111961_b0135","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jdiacomp.2015.02.002","article-title":"Changes in prevalence of diabetic complications and associated healthcare costs during a 10-year follow-up period among a nationwide diabetic cohort","volume":"29","author":"Chen","year":"2015","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabres.2024.111961_b0140","unstructured":"Fang Z, Chang R, Zhang L, Cao W, Li S, Wang Y, Zheng Y, Zheng J. Hospital cost analysis of Chinese patients with diabetes, 2015-20192022."},{"issue":"11","key":"10.1016\/j.diabres.2024.111961_b0145","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1377\/hlthaff.2017.0479","article-title":"Avoidable hospital admissions from diabetes complications in Japan, Singapore, Hong Kong and communities outside Beijing","volume":"36","author":"Quan","year":"2017","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"10.1016\/j.diabres.2024.111961_b0150","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/1753-0407.12428","article-title":"Hospitalization costs and complications in hospitalized patients with type 2 diabetes mellitus in Beijing China","volume":"9","author":"Bao","year":"2017","journal-title":"J Diab"},{"key":"10.1016\/j.diabres.2024.111961_b0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.vhri.2018.02.001","article-title":"Excess hospitalization expenses attributable to type 2 diabetes mellitus in Singapore","volume":"15","author":"Png","year":"2018","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"10.1016\/j.diabres.2024.111961_b0160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s13300-020-00967-y","article-title":"Direct medical costs of incident complications in patients newly diagnosed with type 2 diabetes in China","volume":"12","author":"He","year":"2021","journal-title":"Diabetes Ther"},{"issue":"10267","key":"10.1016\/j.diabres.2024.111961_b0165","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2024.111961_b0170","series-title":"Economic evaluation in clinical trials","author":"Glick","year":"2014"},{"issue":"1","key":"10.1016\/j.diabres.2024.111961_b0175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13561-024-00551-1","article-title":"The temporal and spatial interpretation of China\u2019s health financing: what do Chinese\u2019 government \u2018do\u2019 in new healthcare reform?","volume":"14","author":"Wang","year":"2024","journal-title":"Heal Econ Rev"},{"key":"10.1016\/j.diabres.2024.111961_b0180","unstructured":"Hong Kong Department of Health. Health facts of Hong Kong. Hong Kong2023."},{"key":"10.1016\/j.diabres.2024.111961_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.hpopen.2020.100021","article-title":"Assessing the design of China\u2019s complex health system \u2013 concerns on equity and efficiency","volume":"1","author":"Wang","year":"2020","journal-title":"Health Policy OPEN"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724008714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724008714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T01:56:09Z","timestamp":1740102969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822724008714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":37,"alternative-id":["S0168822724008714"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111961","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal incremental healthcare costs associated with complications in Hong Kong Chinese patients with type 2 diabetes: A prospective study in Joint Asia diabetes evaluation (JADE) Register (2007\u20132019)","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111961"}}